Overview

Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise

Status:
Terminated
Trial end date:
2018-03-09
Target enrollment:
Participant gender:
Summary
The study will consist of two study arms. Each arm will include a 24-96 hour outpatient run-in period prior to their exercise visit wearing the bi-hormonal bionic pancreas. In random order subjects will then complete two approximately 5-hour exercise visits, one wearing the bi-hormonal bionic pancreas and one wearing the insulin-only bionic pancreas.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Glucagon
Glucagon-Like Peptide 1
Insulin
Insulin, Globin Zinc
Pancreatin
Pancrelipase